9 Results

People

  1. Balak
    Balak
  2. De Stanchina
    De Stanchina
  3. Ladanyi
    Ladanyi
  4. Pao
    Pao
  5. Rosen
    Rosen
  6. Somwar
    Somwar
  7. Wendel
    Wendel
  8. Aronowitz
    Aronowitz
  9. Bean
    Bean
  10. Benayed
    Benayed

Groups

  1. GSK Faculty (9)
  2. Sloan Kettering Institute Postdocs (9)
  3. Department of Medicine (7)
  4. Solid Tumor Oncology Division (7)
  5. Human Oncology and Pathogenesis Program (5)
  6. Sloan Kettering Institute Faculty (5)
  7. Breast Medicine Service (3)
  8. Molecular Pharmacology and Chemistry Program Faculty (3)
  9. Thoracic Oncology (3)
  10. Tow Center for Developmental Oncology (TCDO) (3)
  1. "Meeting abstract"
  2. "Sloan Kettering Institute Postdocs"
  3. "Molecular Cancer Therapeutics"
Formats
  1. Meeting Abstract (9)
Groups
  1. GSK Faculty (9)
  2. Sloan Kettering Institute Postdocs (9)
  3. Department of Medicine (7)
  4. Solid Tumor Oncology Division (7)
  5. Human Oncology and Pathogenesis Program (5)
  6. Sloan Kettering Institute Faculty (5)

More Groups

People
  1. Elisa De Stanchina (2)
  2. Hans Wendel (2)
  3. Marc Ladanyi (2)
  4. Marissa Balak (2)
  5. Neal Rosen (2)
  6. Romel Somwar (2)

More People

Years
  1. 2019 (5)
  2. 2015 (1)
  3. 2007 (3)
Publications
  1. Molecular Cancer Therapeutics (9)
Publishers
  1. American Association for Cancer Research (9)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting nucleotide excision repair defects in cancer
    Meeting Abstract

    Topka, S.; Steinsnyder, Z.; Tkachuk, K.; Ravichandran, V.; Madsen, M. W.; Furberg-Barnes, H.; Iyer, G.; De Stanchina, E.; Joseph, V.; Offit, K.
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • Rapid non-uniform adaptation to conformation-specific KRAS G12C inhibition
    Meeting Abstract

    Xue, J.; Zhao, Y.; Aronowitz, J.; Mai, T. T.; Vides, A.; Qeriqi, B.; Kim, D.; Li, C.; de Stanchina, E.; Mazutis, L.; more...
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • eIF4A regulates ERK activation by controlling the translation of DUSP6
    Meeting Abstract

    Xu, J.; Wendel, H. G.; Pelletier, J.; Yao, Z.; Rosen, N.
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • Clinical proof of concept for MCLA-128, a bispecific HER2/3 antibody therapy, in NRG1 fusion-positive cancers
    Meeting Abstract

    Schram, A. M.; O'Reilly, E. M.; Somwar, R.; Benayed, R.; Shameem, S.; Chauhan, T.; Torrisi, J.; Ford, J.; Maussang, D.; Wasserman, E.; more...
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers
    Meeting Abstract

    Chandran, S.; Ma, J.; Klatt, M. G.; Dundar, F.; Zumbo, P.; Femia, M. R.; Betel, D.; Scheinberg, D. A.; Baker, B. M.; Klebanoff, C. A.
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • The 5 UTR of many oncogenes and transcription factors encodes a targetable dependence on the eIF4A RNA helicase
    Meeting Abstract

    Singh, K.; Wolfe, A. L.; Zhong, Y.; Ratsch, G.; Wendel, H. G.
    Molecular Cancer Therapeutics (2015)

    Fulltext@MSK | Save
  • BRAF mutation predicts MEK-dependence in non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Pratilas, C. A.; Halilovic, E.; Persaud, Y.; Sawai, A.; Grbovic-Huezo, O.; Janakiraman, M.; Rosen, N.; Solit, D. B.
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • Identifying strategies to enhance responses induced by EGFR kinase inhibitors in mutant EGFR-dependent lung adenocarcinomas
    Meeting Abstract

    Gong, Y.; Somwar, R.; Politi, K.; Balak, M.; Chmielecki, J.; Jiang, X.; Pao, W.
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
    Meeting Abstract

    Bean, J.; Brennan, C.; Shih, J. Y.; Riely, G.; Viale, A.; Wang, L.; Chitale, D.; Motoi, N.; Szoke, J.; Broderick, S.; more...
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save